PAIGE MYERS MCNAMARA: Open Payments
NPI 1427368786 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 60 payments from 11 companies in 2025. Trend: 2023 $68 · 2024 $848 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 37 | $616 |
| Virtus Pharmaceuticals LLC | 6 | $144 |
| PROTEGA PHARMACEUTIALS INC | 3 | $61 |
| ABBVIE INC. | 2 | $49 |
| SCILEX PHARMACEUTICALS INC. | 2 | $46 |
| MML US, Inc. | 3 | $44 |
| Electronic Waveform Lab, Inc. | 3 | $41 |
| TerSera Therapeutics LLC | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $18 |
Products named: RELISTOR, LEVORPHANOL TARTRATE, ROXYBOND, QULIPTA, ReActiv8, Prialt, ELYXYB - CELECOXIB, ZTLido.
Industry payments across CA — which companies pay providers there.
